AusMed Innovations Drug Test - 11 Panel Urine Cup

Comprehensive 11-panel urine drug screening

Screens for AMP, BZO, BUP, COC, THC, MTD, MET, MOP/OPI, KET, OXY and FYL

Integrated creatinine specimen-integrity check

Rapid chromatographic immunoassay

No instrument or reader required

Visual test results

Built-in procedural control

Convenient urine collection cup format

Individually sealed for use

Suitable for professional point-of-collection screening

Intended for in vitro diagnostic use

Designed for use in accordance with AS/NZS 4308:2023

Product: AusMed Innovations Multi-Drug Rapid Test Cup
Configuration: 11-panel
Specimen: Human urine
Test Type: Rapid chromatographic immunoassay
Creatinine Check: Yes
Result Type: Qualitative preliminary screening
Storage: 2–30°C
Freezing: Do not freeze
Intended Use: In vitro diagnostic use by healthcare professionals and appropriately trained drug-testing personnel

The AusMed Innovations 11 Panel Multi-Drug Rapid Test Cup provides a qualitative preliminary screening result only. Non-negative results should be confirmed using an appropriate laboratory analytical method such as LC-MS/MS or GC-MS, with confirmation performed by a NATA-accredited laboratory where applicable.

The integrated creatinine check provides a semi-quantitative assessment of urinary creatinine and can assist with identifying specimens that may be unusually dilute or otherwise inconsistent with normal human urine.

A non-negative screening result does not indicate a level of intoxication or impairment. A negative result indicates that the concentration is below the applicable screening cut-off and does not necessarily mean that the drug or metabolite is completely absent.

Testing should be perf